Our aim was to elucidate the significance of resistin in the inflammatory process associated with IBD, revealing its utility as a valuable diagnostic marker and monitoring tool, as well as a screening marker for evaluating the effectiveness of therapy. This evidence concerns the gene RETN and inflammatory bowel disease.